Pfizer AG - Dalacin C 300 mg, Hartkapseln | | 35438 | | 05 | | Dalacin C 300 mg | | Hartkapseln | | J01FF01 | | Clindamycin | | 22.08.2006 | | |
| Composition | clindamycinum 300 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 283.27 mg, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. | Packungsbestandteile | | Capsules | | | Active Agent | Dose |
---|
Clindamycin | 300 mg |
| BAG: Active Agent | Dose |
---|
Clindamycin | 300 mg |
| | Inactive agents | Dose | additional_information |
---|
| | | | | | | | color. | | | color. | Gelatina | | Kapselhülle | | | | | | Drucktinte | Lactose Monohydrate | 283.27 mg | | | | | | | | | | | Propylenglycol | | | Talcum | | |
| |
| Teilbarkeit | | | -- | | | | Ja | | | | -- | | | | Ja | | | | Bitterer Geschmack. Alternative: Dalacin C Granulat zur Herstellung einer Suspension (Rezept) | | | | |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
076 | 16 Capsule(s) | 12.93 | 30.40 | A | SL | No |
|
|